Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE).
Oncol Ther
; 10(1): 253-262, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35246827
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Oncol Ther
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
New Zealand